CAS No. |
471-95-4 |
中文名称 |
(3S,5R,8R,9S,10S,13R,14S,16S,17R)-3,14-二羟基-10,13-二甲基-17-(2-氧代-2H-吡喃-5-基)六十氢-1H-环戊二烯并[a]菲-16-基乙酸酯 |
英文名称 |
(3S,5R,8R,9S,10S,13R,14S,16S,17R)-3,14-dihydroxy-10,13-dimethyl-17-(2-oxo-2H-pyran-5-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-16-yl acetate |
别名 |
AKOS030526151 | EINECS 228-208-9 | NCGC00485932-01 | Bufa-20,22-dienolide, 16-(acetyloxy)-3,14-dihydroxy-, (3beta,5beta,16beta)- | (3S,5R,8R,9S,10S,13R,14S,16S,17R)-3,14-dihydroxy-10,13-dimethyl-17-(2-oxo-2H-pyran-5-yl)hexadecahydro-1H-cyclopenta[a]phenan |
标准英文名 |
(3S,5R,8R,9S,10S,13R,14S,16S,17R)-3,14-dihydroxy-10,13-dimethyl-17-(2-oxo-2H-pyran-5-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-16-yl acetate |
MDL No. |
MFCD00210248 |
分子式 |
C26H36O6 |
分子量 |
444.57
|
精确分子量 |
444.25
|
SMILES |
CC(=O)O[C@H]1C[C@]2(O)[C@@H]3CC[C@@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]2(C)[C@H]1C1=COC(=O)C=C1 |
标准SMILES |
CC(=O)O[C@H]1C[C@]2(O)[C@@H]3CC[C@@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]2(C)[C@H]1C1=COC(=O)C=C1 |
用途 |
Bufotalin exhibits potent anti-tumor activity and is used in the treatment of various cancers, including liver cancer, lung cancer, and gastric cancer; it is formulated into oral liquids and tablets for clinical use. Bufotalin induces cancer cell apoptosis and endoplasmic reticulum (ER) stress, triggers cell cycle arrest at the G2/M phase, and is employed in pharmacological research and compound identification/quantification studies. |
InChIKey |
VOZHMAYHYHEWBW-NVOOAVKYSA-N |